JP2011068566A - Sunscreen cosmetic - Google Patents
Sunscreen cosmetic Download PDFInfo
- Publication number
- JP2011068566A JP2011068566A JP2009218817A JP2009218817A JP2011068566A JP 2011068566 A JP2011068566 A JP 2011068566A JP 2009218817 A JP2009218817 A JP 2009218817A JP 2009218817 A JP2009218817 A JP 2009218817A JP 2011068566 A JP2011068566 A JP 2011068566A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- sunscreen
- titanium oxide
- benzotriazole
- sunscreen cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 69
- 230000000475 sunscreen effect Effects 0.000 title claims abstract description 53
- 239000000516 sunscreening agent Substances 0.000 title claims abstract description 53
- 239000000843 powder Substances 0.000 claims abstract description 46
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 43
- 229920005989 resin Polymers 0.000 claims abstract description 41
- 239000011347 resin Substances 0.000 claims abstract description 41
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims abstract description 37
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 14
- 150000001565 benzotriazoles Chemical class 0.000 claims description 19
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 12
- XPSDDCQPLUUXMQ-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-5-(2-ethylhexoxy)phenol Chemical group OC1=CC(OCC(CC)CCCC)=CC=C1N1N=C2C=CC=CC2=N1 XPSDDCQPLUUXMQ-UHFFFAOYSA-N 0.000 claims description 8
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 150000004665 fatty acids Chemical class 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- RQBIEDTZMMIIGG-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-5-(2-methylpropoxy)phenol Chemical compound OC1=CC(OCC(C)C)=CC=C1N1N=C2C=CC=CC2=N1 RQBIEDTZMMIIGG-UHFFFAOYSA-N 0.000 claims description 3
- 239000011882 ultra-fine particle Substances 0.000 abstract description 7
- 125000003354 benzotriazolyl group Chemical class N1N=NC2=C1C=CC=C2* 0.000 abstract 1
- 239000002245 particle Substances 0.000 description 29
- 238000010521 absorption reaction Methods 0.000 description 21
- 239000003921 oil Substances 0.000 description 21
- -1 2-hydroxy-4-isobutoxyphenyl Chemical group 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 15
- 239000010419 fine particle Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 13
- 239000006096 absorbing agent Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 238000003786 synthesis reaction Methods 0.000 description 11
- 238000003756 stirring Methods 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000002585 base Substances 0.000 description 9
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 239000012071 phase Substances 0.000 description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 8
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 7
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 7
- 229940063655 aluminum stearate Drugs 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 5
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 230000006750 UV protection Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 4
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 150000002736 metal compounds Chemical class 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 239000011787 zinc oxide Substances 0.000 description 4
- NZWIYPLSXWYKLH-UHFFFAOYSA-N 3-(bromomethyl)heptane Chemical compound CCCCC(CC)CBr NZWIYPLSXWYKLH-UHFFFAOYSA-N 0.000 description 3
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 3
- 239000012964 benzotriazole Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000004584 polyacrylic acid Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 0 *c1ccc(*2*(O)=C(C=CC=C3)C3=*2)c(*)c1 Chemical compound *c1ccc(*2*(O)=C(C=CC=C3)C3=*2)c(*)c1 0.000 description 2
- 150000000182 1,3,5-triazines Chemical class 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- LEBRCVXHIFZXEM-UHFFFAOYSA-N 4-(benzotriazol-2-yl)benzene-1,3-diol Chemical compound OC1=CC(O)=CC=C1N1N=C2C=CC=CC2=N1 LEBRCVXHIFZXEM-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 2
- 239000004115 Sodium Silicate Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 150000008366 benzophenones Chemical class 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 2
- 229910052911 sodium silicate Inorganic materials 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 229920005992 thermoplastic resin Polymers 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FIDRAVVQGKNYQK-UHFFFAOYSA-N 1,2,3,4-tetrahydrotriazine Chemical class C1NNNC=C1 FIDRAVVQGKNYQK-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- SVPKNMBRVBMTLB-UHFFFAOYSA-N 2,3-dichloronaphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(Cl)=C(Cl)C(=O)C2=C1 SVPKNMBRVBMTLB-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- COXCGWKSEPPDAA-UHFFFAOYSA-N 2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)C#N COXCGWKSEPPDAA-UHFFFAOYSA-N 0.000 description 1
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical compound OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 description 1
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical compound NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- PFHLGILELJGQSJ-UHFFFAOYSA-N 4-(2h-benzotriazol-4-ylmethyl)-2h-benzotriazole;2-butyl-3,4,5,6-tetramethylphenol Chemical compound CCCCC1=C(C)C(C)=C(C)C(C)=C1O.C=1C=CC=2NN=NC=2C=1CC1=CC=CC2=C1N=NN2 PFHLGILELJGQSJ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- OEOIWYCWCDBOPA-UHFFFAOYSA-N 6-methyl-heptanoic acid Chemical compound CC(C)CCCCC(O)=O OEOIWYCWCDBOPA-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical class CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 241000269837 Artemisia dubia Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- WRYHIWRRDHAORK-UHFFFAOYSA-N CCCCCCCCCCCCCCCCCC[NH3+].CCCCCCCCCCCCCCCCCC[NH3+].[Cl-].[Cl-] Chemical compound CCCCCCCCCCCCCCCCCC[NH3+].CCCCCCCCCCCCCCCCCC[NH3+].[Cl-].[Cl-] WRYHIWRRDHAORK-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000422842 Chamaecyparis pisifera Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 239000005046 Chlorosilane Substances 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- JSCQSBGXKRTPHZ-UHFFFAOYSA-N Mucidin Natural products COC=C(C(=O)OC)C(C)=CC=CC1=CC=CC=C1 JSCQSBGXKRTPHZ-UHFFFAOYSA-N 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 229930192627 Naphthoquinone Natural products 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- JSCQSBGXKRTPHZ-WMSPMLHYSA-N Strobilurin A Natural products COC=C(/C(=C/C=C/c1ccccc1)/C)C(=O)OC JSCQSBGXKRTPHZ-WMSPMLHYSA-N 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical compound Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000010556 emulsion polymerization method Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011817 metal compound particle Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- JSCQSBGXKRTPHZ-SYKZHUKTSA-N mucidin Chemical compound CO\C=C(\C(=O)OC)/C(/C)=C\C=C\C1=CC=CC=C1 JSCQSBGXKRTPHZ-SYKZHUKTSA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920006284 nylon film Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-UHFFFAOYSA-N octinoxate Chemical compound CCCCC(CC)COC(=O)C=CC1=CC=C(OC)C=C1 YBGZDTIWKVFICR-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 239000004533 oil dispersion Substances 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000003505 polymerization initiator Substances 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000010558 suspension polymerization method Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- QPQANCNBWQXGTQ-UHFFFAOYSA-N trihydroxy(trimethylsilylperoxy)silane Chemical compound C[Si](C)(C)OO[Si](O)(O)O QPQANCNBWQXGTQ-UHFFFAOYSA-N 0.000 description 1
- SCRSFLUHMDMRFP-UHFFFAOYSA-N trimethyl-(methyl-octyl-trimethylsilyloxysilyl)oxysilane Chemical compound CCCCCCCC[Si](C)(O[Si](C)(C)C)O[Si](C)(C)C SCRSFLUHMDMRFP-UHFFFAOYSA-N 0.000 description 1
- 229960005066 trisodium edetate Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は日焼け止め化粧料に関する。さらに詳しくは、優れた使用感と紫外線吸収効果とを有する日焼け止め化粧料に関する。 The present invention relates to a sunscreen cosmetic. More specifically, the present invention relates to a sunscreen cosmetic having an excellent feeling of use and an ultraviolet absorption effect.
日焼け止め化粧料による重要な紫外線吸収波長領域は、UV−A領域(320〜400nm)とUV−B領域(290〜320nm)である。そして、UV−A領域(320〜400nm)の紫外線は皮膚を黒く侵すが、UV−B領域(290〜320nm)の紫外線のようにサンバーンを起こし、皮膚の老化を促進させるものではないと考えられていた。ところが近年になってUV−B領域の紫外線が比較的、皮膚の表面部分にとどまるのに対してUV−A領域の紫外線が、皮膚の深部にまで達し、皮膚の老化はもとより皮膚癌を誘発する原因となることがわかってきた。 The important ultraviolet absorption wavelength regions by sunscreen cosmetics are the UV-A region (320 to 400 nm) and the UV-B region (290 to 320 nm). UV rays in the UV-A region (320 to 400 nm) invade the skin black, but it is considered that sunburn occurs like the ultraviolet rays in the UV-B region (290 to 320 nm) and does not promote skin aging. It was. However, in recent years, ultraviolet rays in the UV-B region stay relatively on the surface of the skin, whereas ultraviolet rays in the UV-A region reach the deep part of the skin, and induce skin cancer as well as skin aging. It has been found to be the cause.
今日までに使用されてきた化粧料用紫外線吸収剤は、構造面から分類すると、(1)安息香酸誘導体、(2)ケイ皮酸誘導体、(3)ベンゾフェノン誘導体、(4)ジベンゾイルメタン誘導体、(5)サリチル酸誘導体等がある。そして近年は、(2)と(4)の紫外線吸収剤が多用されている。 Cosmetic UV absorbers that have been used to date are classified according to the structure: (1) benzoic acid derivatives, (2) cinnamic acid derivatives, (3) benzophenone derivatives, (4) dibenzoylmethane derivatives, (5) Salicylic acid derivatives and the like. In recent years, the ultraviolet absorbers (2) and (4) are frequently used.
しかしながら、上記にあげた紫外線吸収剤は、実用面から見るとそれぞれに問題がある。例えば、(1)の安息香酸誘導体では、例えばp−ジメチルアミノ安息香酸−2−エチルヘキシルは、液状、透明であり、扱いやすい長所はあるが、これらの誘導体を含めて安全性の疑いがあり、近年は使用されていない。また、極大吸収波長が290nm付近にあり、UV−B領域のみの紫外線を吸収する。 However, the ultraviolet absorbers listed above have their respective problems from a practical standpoint. For example, in the benzoic acid derivative of (1), for example, p-dimethylaminobenzoic acid-2-ethylhexyl is liquid and transparent, and has advantages that it is easy to handle, but there is a suspicion of safety including these derivatives. It has not been used in recent years. Further, the maximum absorption wavelength is in the vicinity of 290 nm, and the ultraviolet ray only in the UV-B region is absorbed.
(2)のケイ皮酸誘導体では、現在市販されているサンケア化粧品に最もよく使用されている紫外線吸収剤として、p−メトキシケイ皮酸−2−エチルヘキシルエステルがある。極大吸収波長は310nm付近にあり、吸収域がUV−A領域には及ばない。また、日光により変質して着色性や紫外線防御効果の持続性に問題がある。 In the cinnamic acid derivative (2), there is p-methoxycinnamic acid-2-ethylhexyl ester as an ultraviolet absorber most frequently used in sun care cosmetics currently on the market. The maximum absorption wavelength is around 310 nm, and the absorption region does not reach the UV-A region. In addition, the color changes due to sunlight and there is a problem in the sustainability of the coloring property and the UV protection effect.
(3)のベンゾフェノン誘導体では、例えば2−ヒドロキシ−4−メトキシベンゾフェノンがUV−A、UV−B領域にわたって吸収があり、比較的皮膚外用剤基剤への溶解性も良いが、極大吸収波長がややUV−B領域に近いところにあり、吸光度もあまり大きくない。 In the benzophenone derivative of (3), for example, 2-hydroxy-4-methoxybenzophenone has absorption over the UV-A and UV-B regions and has relatively good solubility in a skin external preparation base, but has a maximum absorption wavelength. Slightly close to the UV-B region and the absorbance is not very large.
(4)のジベンゾイルメタン誘導体では、4−tert−ブトキシ−4−メトキシジベンゾイルメタンがよく皮膚外用剤に使用されている。極大吸収が360nm付近にあり、吸光度も大きく、UV−A領域の紫外線吸収剤として優れている。しかしながら、光安定性に問題があり、皮膚外用剤用の油分に対しての相溶性が悪く、少量しか混合できない。 Of the dibenzoylmethane derivatives of (4), 4-tert-butoxy-4-methoxydibenzoylmethane is often used as a skin external preparation. The maximum absorption is in the vicinity of 360 nm, the absorbance is large, and it is excellent as an ultraviolet absorber in the UV-A region. However, there is a problem in light stability, the compatibility with the oil for skin external preparation is poor, and only a small amount can be mixed.
(5)のサリチル酸誘導体では、サリチル酸オクチルが使われている。UV−B領域に極大吸収波長をもち、オイル状であり、パラフィンオイル等の相溶性に優れるが吸光度が低いため、あまり実用化されていない。 In the salicylic acid derivative (5), octyl salicylate is used. It has a maximum absorption wavelength in the UV-B region, is oily, and is excellent in compatibility with paraffin oil or the like, but is not practically used because of its low absorbance.
このため、UV−B領域においては、(2)のp−メトキシケイ皮酸−2−エチルヘキシルが、UV−A領域に関しては(4)の4−tert−ブチル−4−メトキシジベンゾイルメタンが使用されることが多い。特に近年では、UV−A領域の紫外線吸収に対する要求が高まっている。 For this reason, 2-ethylhexyl p-methoxycinnamate (2) is used in the UV-B region, and 4-tert-butyl-4-methoxydibenzoylmethane (4) is used in the UV-A region. Often done. Particularly in recent years, there has been an increasing demand for ultraviolet absorption in the UV-A region.
一方、紫外線吸収剤の中にはべたつきを有するものがあり、使用感を重要視する日焼け止め化粧料への配合においては大きな問題となる場合がある。すなわち、高い紫外線吸収効果を発揮させるために、紫外線吸収剤の配合量を多めにする場合に、その使用感は極端に悪くなる。したがって、希望の紫外線吸収剤を希望する配合量だけ配合できない場合がある。 On the other hand, some ultraviolet absorbers have stickiness, and may be a major problem in blending into sunscreen cosmetics where the feeling of use is important. That is, when the blending amount of the ultraviolet absorber is increased in order to exhibit a high ultraviolet absorption effect, the feeling of use becomes extremely worse. Therefore, the desired ultraviolet absorber may not be blended in the desired blending amount.
また、一般に、幅広い吸収領域を確保する観点から、複数の紫外線吸収剤を日焼け止め化粧料に配合することは行われる。
しかしながら、紫外線吸収剤を配合する日焼け止め化粧料においては、その使用感が低下する場合がある。優れた使用感は化粧料に強く要求される重要な要素になるため、幅広い吸収領域を確保するためであっても、複数の異なる紫外線吸収剤を配合することは通常行われてはいない。
In general, from the viewpoint of securing a wide absorption region, a plurality of ultraviolet absorbers are blended into a sunscreen cosmetic.
However, in sunscreen cosmetics containing an ultraviolet absorber, the feeling of use may be reduced. Since an excellent feeling of use becomes an important factor strongly demanded for cosmetics, blending a plurality of different ultraviolet absorbers is not usually performed even in order to secure a wide absorption region.
一方、化粧料に紫外線吸収剤として配合されるジベンゾイルメタン誘導体は、光暴露による紫外線照射下でのUV吸収能が低下する。この現象を抑制する光安定性を確保するため、ベンゾイルメタン誘導体と他の紫外線吸収剤であるα−シアノ−β,β−ジフェニルアクリレートとを併用する技術が開発されている(特許文献1)。 On the other hand, a dibenzoylmethane derivative blended as a UV absorber in cosmetics has a reduced UV absorbing ability under UV irradiation due to light exposure. In order to ensure the light stability which suppresses this phenomenon, the technique which uses together a benzoylmethane derivative and (alpha) -cyano-beta, (beta) -diphenylacrylate which is another ultraviolet absorber (patent document 1) is developed.
また、紫外線吸収剤の1,3,5−トリアジン誘導体とジベンゾイルメタン誘導体とを併用した化粧料においては、4−tert−ブチル−4’−メトキシジベンゾイルメタンが存在すると、紫外線照射により1,3,5−トリアジン誘導体が化学的に大きく劣化する。そのため、1,3,5−トリアジン誘導体とジベンゾイルメタン誘導体との光安定性を確保するため、α−シアノ−β,β−ジフェニルアクリレートを併用する技術が開発されている(特許文献2)。
Further, in cosmetics using a
しかしながら、複数の紫外線吸収剤の併用により紫外線吸収剤自体の光安定性を確保する技術には問題がある。なぜなら、紫外線吸収剤は化粧料基材である油分との相溶性が低く難溶のため、これを化粧料に安定配合するためには相溶性に優れた特定油分を多量に配合する必要が生じる。そして、そのような特定油分を多量に配合すると、化粧料の安定性(特に油中水型乳化化粧料の乳化安定性)の低下や使用感の低下を招く要因になってしまう。 However, there is a problem in the technology for ensuring the light stability of the ultraviolet absorber itself by using a plurality of ultraviolet absorbers in combination. This is because UV absorbers have low compatibility with oils that are cosmetic bases and are hardly soluble. Therefore, it is necessary to add a large amount of specific oils with excellent compatibility in order to stably mix them with cosmetics. . And when such a specific oil content is blended in a large amount, it becomes a factor that causes a decrease in the stability of the cosmetic (particularly the emulsification stability of the water-in-oil emulsified cosmetic) and a feeling of use.
また、日焼け止め化粧料には、紫外線防御効果を上げるために、紫外線吸収剤と共に、紫外線散乱剤として酸化亜鉛及び/又は酸化チタンの微粒子粉末を配合することが多い。
しかしながら、微粒子粉末を配合すると、紫外線吸収剤による衣服への汚着が生じたり、塗布後に白くなってしまうという課題も生じる。
In addition, sunscreen cosmetics often contain fine particles of zinc oxide and / or titanium oxide as an ultraviolet scattering agent together with an ultraviolet absorber in order to increase the ultraviolet protection effect.
However, when the fine particle powder is blended, there is a problem that the ultraviolet absorbent absorbs clothes or becomes white after application.
以上のように、日焼け止め化粧料に、複数の異なる紫外線吸収剤や紫外線散乱剤の粉末を配合すること対しては技術的な困難な側面があり、複数の紫外線吸収剤や紫外線散乱剤との併用が容易に行われることがない事情が存在する。 As described above, there are technical difficulties in blending sunscreen cosmetics with a plurality of different ultraviolet absorbers and powders of ultraviolet scattering agents. There are circumstances where the combined use is not easily performed.
なお、下記一般式(I)で示されるベンゾトリアゾール誘導体は、UV―A領域の化粧料用の紫外線吸収剤として特許文献3に詳述されている。
一般式(I)
Formula (I)
一方、樹脂の中に酸化チタンの粉末を内包する酸化チタン樹脂粉末を配合する化粧料はメーキャップ化粧料として広く知られている。また、紫外線遮蔽性を付与した化粧料に関し、金属酸化物粒子を樹脂粉体に含有させて使用することにより、化粧料の原料として金属酸化物の微粒子を使用する場合に伴う技術的困難さと有機系紫外線吸収剤のみを用いることによる弊害とを解消できるようにすることを課題とし、この課題を解決するため、紫外線遮蔽能を有する平均粒子径0.003〜0.1μmの金属酸化物を内包させた樹脂粉体からなり、該樹脂粉体を化粧料に配合することが知られている(特許文献4)。さらに、化粧料の可視光線透過型原料として適した球状樹脂粉体及びその製造方法とこれを使用した化粧品に関して、金属化合物粒子を樹脂粉体に含有させて使用することにより、有機系紫外線吸収剤を不要にし、化粧料の原料として金属化合物の微粒子を使用する場合に伴う技術的困難さと有機系紫外線吸収剤の存在に伴う弊害とを解消できるようにすることが知られている(特許文献5)。 On the other hand, cosmetics containing titanium oxide resin powder containing titanium oxide powder in a resin are widely known as makeup cosmetics. In addition, regarding cosmetics imparted with ultraviolet shielding properties, the use of metal oxide particles contained in resin powder makes it possible to use the technical difficulties and organicities associated with the use of metal oxide fine particles as a raw material for cosmetics. Resin encapsulating metal oxides with an average particle diameter of 0.003 to 0.1 μm having an ultraviolet shielding ability in order to solve the problems caused by the use of only an ultraviolet absorber It is known to be composed of powder and to blend the resin powder into cosmetics (Patent Document 4). Furthermore, regarding a spherical resin powder suitable as a visible light transmissive raw material for cosmetics, a method for producing the same, and a cosmetic using the same, an organic ultraviolet absorber can be obtained by using metal compound particles contained in the resin powder. It is known that the technical difficulty associated with the use of metal compound fine particles as a cosmetic raw material and the adverse effects associated with the presence of organic ultraviolet absorbers can be eliminated (Patent Document 5). ).
本発明者は上述した観点に鑑み、優れた紫外線吸収効果を有し、かつ使用感に優れた日焼け止め化粧料について鋭意研究を重ねた結果、特定紫外線吸収剤と紫外線散乱剤の粉末とを配合すると優れた紫外線防御効果を発揮して高いSPFを有する日焼け止め化粧料を提供できることを見出した。さらに、疎水化処理した超微粒子酸化チタン、特に脂肪酸アルミニウムで処理した超微粒子酸化チタンと紫外線吸収剤とを配合すると、酸化チタン粉末特有の「きしみ感」が生じることを見出したが、本発明によればこれを見事に解決できることをも見出して本発明を完成するに至った。 In view of the above-mentioned viewpoints, the present inventors have conducted extensive research on sunscreen cosmetics having an excellent ultraviolet absorption effect and excellent usability. As a result, a specific ultraviolet absorber and a powder of an ultraviolet scattering agent are blended. Then, it discovered that the sunscreen cosmetics which exhibit the outstanding ultraviolet-ray protective effect and have high SPF can be provided. Furthermore, it has been found that, when ultrafine titanium oxide treated with hydrophobization, particularly ultrafine titanium oxide treated with fatty acid aluminum, and an ultraviolet absorber are blended, a “squeaking sensation” peculiar to titanium oxide powder occurs. Thus, the inventors have found that this can be solved brilliantly and have completed the present invention.
本発明の目的は、優れた使用感を有し、かつ優れた紫外線吸収効果による高いSPFを有する日焼け止め化粧料を提供することにある。 An object of the present invention is to provide a sunscreen cosmetic having an excellent feeling of use and having a high SPF due to an excellent ultraviolet absorption effect.
すなわち、本発明は、
(1)下記一般式(I)で示されるベンゾトリアゾール誘導体と、
一般式(I)
(2)内部に疎水化処理された超微粒子酸化チタンを35質量%以上含有した樹脂球状粉末と
を配合することを特徴とする日焼け止め化粧料を提供するものである。
That is, the present invention
(1) a benzotriazole derivative represented by the following general formula (I);
Formula (I)
(2) Provided is a sunscreen cosmetic characterized in that it contains a spherical resin powder containing 35% by mass or more of ultrafine titanium oxide that has been hydrophobized.
また、本発明は、前記ベンゾトリアゾール誘導体が、2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール、2−(2−ヒドロキシ−4−イソブトキシフェニル)−2H−ベンゾトリアゾールから選ばれる1種または2種以上であることを特徴とする上記の皮膚外用剤を提供するものである。 In the present invention, the benzotriazole derivative may be 2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole, 2- (2-hydroxy-4-isobutoxyphenyl) -2H. -The above-mentioned skin external preparation characterized by being 1 type, or 2 or more types chosen from benzotriazole.
さらに、本発明は、前記疎水化処理された超微粒子酸化チタンが脂肪酸アルミニウムによって処理されたものであることを特徴とする上記の日焼け止め化粧料を提供するものである。 Furthermore, the present invention provides the sunscreen cosmetic described above, wherein the hydrophobized ultrafine titanium oxide is treated with fatty acid aluminum.
また、本発明は、さらに(3)p−メトキシケイ皮酸2−エチルヘキシルを配合することを特徴とする上記の日焼け止め化粧料を提供するものである。 In addition, the present invention provides (3) the sunscreen cosmetic described above, which further comprises (3) 2-ethylhexyl p-methoxycinnamate.
さらに、本発明は、前記ベンゾトリアゾール誘導体とp−メトキシケイ皮酸2−エチルヘキシルの配合質量比が8:2〜2:8であることを特徴とする上記の日焼け止め化粧料を提供するものである。 Furthermore, the present invention provides the sunscreen cosmetic described above, wherein the blending mass ratio of the benzotriazole derivative and 2-ethylhexyl p-methoxycinnamate is 8: 2 to 2: 8. is there.
また、本発明は、前記日焼け止め化粧料が油中水型乳化化粧料であることを特徴とする上記の日焼け止め化粧料を提供するものである。 The present invention also provides the sunscreen cosmetic described above, wherein the sunscreen cosmetic is a water-in-oil emulsified cosmetic.
本発明の日焼け止め化粧料は、優れた使用感と優れた紫外線吸収効果を有する。特に、本発明の日焼け止め化粧料は、優れた紫外線防御効果を発揮させるために紫外線散乱剤の粉末が配合されていても、粉末特有のきしみ感が少なく、粉っぽくもない優れた使用感を有する。 The sunscreen cosmetic of the present invention has an excellent feeling of use and an excellent ultraviolet absorption effect. In particular, the sunscreen cosmetic of the present invention has an excellent feeling of use that is less powdery and squeaky, even when a powder of an ultraviolet scattering agent is blended in order to exhibit an excellent UV protection effect. Have
以下、本発明について詳述する。 Hereinafter, the present invention will be described in detail.
「(1)下記一般式(I)で示されるベンゾトリアゾール誘導体」
下記一般式(I)で示されるベンゾトリアゾール誘導体は公知の化合物であり、以下のようにして合成する。すなわち、o−ニトロアニリンを亜硝酸ソーダ等でジアゾニウム塩とし、フェノールとカップリングしてモノアゾ化合物を合成した後、還元してベンゾトリアゾールとする方法が一般的である。
(A法)
第1工程
第5工程
(B法)
第1工程
A benzotriazole derivative represented by the following general formula (I) is a known compound and is synthesized as follows. That is, a method is generally used in which o-nitroaniline is converted to a diazonium salt with sodium nitrite or the like, coupled with phenol to synthesize a monoazo compound, and then reduced to benzotriazole.
(Method A)
First step
5th process
(Method B)
First step
また、対応するベンゾトリアゾールと、ハロゲン化アルキルとをメチルイソブチルケトンとジメチルホルムアミドとの混合溶媒中にて還流すると、特に高い収率で一般式(I)の化合物が製造できる。
より具体的に説明すれば、6−(2H−ベンゾトリアゾール−2−イル)レゾルシノールを、温度計と還流冷却器を備えた四つ口フラスコに入れ、メチルイソブチルケトンとジメチルホルムアミドとを加えて撹拌する。この中に炭酸ソーダと2−エチルヘキシルブロマイドとを加えて撹拌しながら還流温度まで加熱する。還流温度を保持しながら所定時間撹拌した後、メチルイソブチルケトンを常圧で回収して残留したオイルを水洗にて過剰の炭酸ソーダと生成した無機物を除去し、さらに精製して、2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールが高い収率で得られる。
When the corresponding benzotriazole and alkyl halide are refluxed in a mixed solvent of methyl isobutyl ketone and dimethylformamide, the compound of the general formula (I) can be produced with a particularly high yield.
More specifically, 6- (2H-benzotriazol-2-yl) resorcinol is placed in a four-necked flask equipped with a thermometer and a reflux condenser, and methyl isobutyl ketone and dimethylformamide are added and stirred. To do. Sodium carbonate and 2-ethylhexyl bromide are added to this, and it heats to reflux temperature, stirring. After stirring for a predetermined time while maintaining the reflux temperature, methyl isobutyl ketone was recovered at normal pressure, and the remaining oil was washed with water to remove excess sodium carbonate and generated inorganic substances, and further purified to give 2- [4 -(2-Ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole is obtained in high yield.
本発明においては、前記ベンゾトリアゾール誘導体が、2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾール、及び/又は、2−(2−ヒドロキシ−4−イソブトキシフェニル)−2H−ベンゾトリアゾールであることが好ましい。特に好ましくは、2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールであり、化粧料基剤に対して優れた溶解安定性を有する。 In the present invention, the benzotriazole derivative is 2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole and / or 2- (2-hydroxy-4-isobutoxyphenyl). ) -2H-benzotriazole. Particularly preferred is 2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole, which has excellent dissolution stability for cosmetic bases.
上記(1)のベンゾトリアゾール誘導体の配合量の合計は特に限定されないが、日焼け止め化粧料全量に対して、通常0.1〜20質量%であり、0.5〜10質量%であることが好ましく、1.0〜3.0質量%であることがさらに好ましい。 Although the sum total of the compounding quantity of the benzotriazole derivative of said (1) is not specifically limited, It is 0.1-20 mass% normally with respect to the total amount of sunscreen cosmetics, and it may be 0.5-10 mass%. Preferably, it is 1.0-3.0 mass%.
「樹脂球状粉末」
本発明に用いる樹脂球状粉末は、内部に疎水化処理された超微粒子酸化チタンを35質量%以上含有した樹脂球状粉末である。
本発明において、超微粒子酸化チタンとは、その平均粒子径が10nm〜100nmの超微粒子酸化チタン粉末である。平均粒子径はレーザー粒度分布計を用いて常法により測定される値である。
樹脂球状粉末の樹脂とは、球状樹脂の内部に疎水化処理された超微粒子酸化チタンを35質量%以上含有する樹脂粉末である。球状樹脂粉末に超微粒子酸化チタンが内包された樹脂粉末は公知であるが、含有率が34質量%以下では含有量が少なすぎ、例えば、超微粒子酸化チタンを含有する樹脂粉体を化粧料に配合して紫外線防御能を化粧料に与えようとしても、十分に性能を発揮させるためには樹脂粉体を大量に配合しなければならず、化粧料の配合設計が極めて難しくなる。
また、疎水化処理されていない超微粒子酸化チタンでは、重合前の分散液を製造する段階で、この分散液の粘度が非常に高くなり、金属化合物の微粒子に対し効果的に分散エネルギーを与えることができずに、金属化合物の微粒子を高分散状態にすることは困難になる。このため、金属化合物の凝集物が残ったり、不均一になったりして均一な樹脂粉体を製造することはできなくなる。
超微粒子酸化チタンを35質量%以上もの高い含有率で内包された粉末は化粧料原料として使用されたことはない。
<樹脂球状粉末の製法>
樹脂球状粉末を製造するには、懸濁重合法、乳化重合法、樹脂溶液を機械的に分散又は乳化する方法、樹脂溶液から微粒子を析出させる方法等が知られている。母材粒子の内部に含有率が40重量%を超える疎水化処理微粒子酸化チタンを分散させる方法は、例えば、母材粒子がナイロン樹脂の場合には、パラフィン等に環状ラクタムを加熱、溶解し、これに所望量の二酸化チタン微粉末を添加し、かき混ぜながら、重合促進剤、例えば三塩化リンを添加してアルカリ重合を行わせ、得られた粒子をろ別し、有機溶剤、例えばベンゼンやイソプロピルアルコールで洗浄し、乾燥する方法が挙げられる。
母材粒子がシリコーン樹脂の場合には、アンモニアやアミン等の水溶液に二酸化チタンや酸化亜鉛の微粉末を添加、混合し、更に、加水分解性シラン、例えばクロロシラン、ハイドロジェンシラン、アルコキシシラン、アセトキシシランを加えて加水分解、縮合反応を行わせ、得られた粒子をろ別し、水洗し、乾燥する方法が挙げられる。
また、母材粒子が酸化ケイ素の場合には、まず、ケイ酸ナトリウムに二酸化チタンや酸化亜鉛の微粉末を添加して懸濁液を調製し、更に界面活性剤とベンゼン等の油性分散剤との混合液を調製し、この混合液に上述した懸濁液を加え、乳化させて油中水分散型エマルジョンを得た後、それを硫酸アンモニウムや塩化アンモニウム等の塩を添加してケイ酸ナトリウムと反応させ、得られた粒子をろ別、水洗し、メタノール等の有機溶剤で洗浄し、乾燥する方法などが挙げられる。
さらに、好適な製法として非水溶性の熱可塑性樹脂を200℃程度の高温下で液状にしておき、そこに疎水化処理した微粒子酸化チタンを分散させた後、当該分散液を水溶性材料(オリゴ糖など)に分散して冷却固化した後、水洗により水溶性材料を除去して、非水溶性の熱可塑性樹脂と疎水化処理した微粒子酸化チタンからなる真球状微粒子を得る方法が挙げられる。
"Resin spherical powder"
The spherical resin powder used in the present invention is a spherical resin powder containing 35% by mass or more of ultrafine titanium oxide hydrophobized inside.
In the present invention, ultrafine titanium oxide is ultrafine titanium oxide powder having an average particle size of 10 nm to 100 nm. The average particle diameter is a value measured by a conventional method using a laser particle size distribution meter.
The resin of the spherical resin powder is a resin powder containing 35% by mass or more of ultrafine titanium oxide hydrophobized inside the spherical resin. A resin powder in which ultrafine titanium oxide is encapsulated in a spherical resin powder is known, but if the content is 34% by mass or less, the content is too small. For example, a resin powder containing ultrafine titanium oxide is used as a cosmetic. Even when blended to give UV protection ability to cosmetics, a large amount of resin powder must be blended in order to achieve sufficient performance, and the blending design of the cosmetics becomes extremely difficult.
In addition, with ultrafine titanium oxide that has not been hydrophobized, the viscosity of the dispersion becomes very high at the stage of producing the dispersion before polymerization, and the dispersion energy is effectively given to the fine particles of the metal compound. However, it becomes difficult to make the metal compound fine particles highly dispersed. For this reason, aggregates of the metal compound remain or become non-uniform, making it impossible to produce a uniform resin powder.
A powder encapsulating ultrafine titanium oxide at a high content of 35% by mass or more has never been used as a cosmetic raw material.
<Production method of spherical resin powder>
In order to produce a resin spherical powder, a suspension polymerization method, an emulsion polymerization method, a method of mechanically dispersing or emulsifying a resin solution, a method of depositing fine particles from the resin solution, and the like are known. The method for dispersing the hydrophobized fine particle titanium oxide having a content of more than 40% by weight inside the base material particles is, for example, when the base material particles are nylon resin, heating and dissolving the cyclic lactam in paraffin or the like, A desired amount of titanium dioxide fine powder is added to this, and while stirring, a polymerization accelerator such as phosphorus trichloride is added to cause alkali polymerization, and the resulting particles are filtered off, and an organic solvent such as benzene or isopropyl is added. A method of washing with alcohol and drying is exemplified.
When the base material particle is a silicone resin, a fine powder of titanium dioxide or zinc oxide is added to and mixed with an aqueous solution of ammonia or amine, and further hydrolyzable silane such as chlorosilane, hydrogensilane, alkoxysilane, acetoxy Examples of the method include adding silane to cause hydrolysis and condensation reaction, filtering the obtained particles, washing with water, and drying.
When the base material particles are silicon oxide, first, a suspension is prepared by adding fine powder of titanium dioxide or zinc oxide to sodium silicate, and further, a surfactant and an oily dispersant such as benzene are added. After adding the above-mentioned suspension to this mixture and emulsifying it to obtain a water-in-oil dispersion emulsion, it is added with a salt such as ammonium sulfate or ammonium chloride to add sodium silicate and Examples include a method of reacting and filtering the obtained particles, washing with water, washing with an organic solvent such as methanol, and drying.
Further, as a suitable production method, a water-insoluble thermoplastic resin is made into a liquid at a high temperature of about 200 ° C., and the fine particle titanium oxide hydrophobized is dispersed therein. For example, there may be mentioned a method in which water-soluble materials are removed by washing with water to obtain true spherical fine particles composed of a water-insoluble thermoplastic resin and hydrophobized fine particle titanium oxide.
その樹脂球状粉末の平均粒子径は1〜10μmであり、1〜5μmが好ましい。平均粒子径はレーザー粒度分布計を用いて常法により測定される値である。
疎水化処理するための処理剤は限定されないがステアリン酸アルミニウム・メチルハイドロジェンポリシロキサン・アルキルトリエトキシシランなどが好ましく、常法により疎水化処理される。
The average particle diameter of the resin spherical powder is 1 to 10 μm, preferably 1 to 5 μm. The average particle diameter is a value measured by a conventional method using a laser particle size distribution meter.
The treatment agent for the hydrophobic treatment is not limited, but aluminum stearate, methylhydrogenpolysiloxane, alkyltriethoxysilane and the like are preferable, and the hydrophobic treatment is performed by a conventional method.
樹脂球状粉末の配合量は、日焼け止め化粧料全量に対して、通常1〜40質量%が配合される。3〜30質量%が好ましく、5〜20質量%がさらに好ましい。 As for the compounding quantity of resin spherical powder, 1-40 mass% is normally mix | blended with respect to the sunscreen cosmetics whole quantity. 3-30 mass% is preferable and 5-20 mass% is further more preferable.
「(3)p−メトキシケイ皮酸−2−エチルヘキシル」
本発明の日焼け止め化粧料には、紫外線吸収剤の上記特定のベンゾトリアゾール誘導体と紫外線散乱剤の上記特定の樹脂球状粉末である超微粒子酸化チタンの他に、p−メトキシケイ皮酸−2−エチルヘキシルを組み合わせて配合することが好ましい。p−メトキシケイ皮酸−2−エチルヘキシルは公知の紫外線吸収剤であり市販品を使用できる。例えば、「PARSOL MCX」(DSM Nutritional Products)が市販されている。
“(3) p-methoxycinnamic acid-2-ethylhexyl”
The sunscreen cosmetics of the present invention include p-methoxycinnamic acid-2-acid in addition to the above-mentioned specific benzotriazole derivative of an ultraviolet absorber and the ultrafine particle titanium oxide which is the above-mentioned specific resin spherical powder of an ultraviolet scattering agent. It is preferable to combine ethylhexyl in combination. p-Methoxycinnamic acid-2-ethylhexyl is a known ultraviolet absorber, and a commercially available product can be used. For example, “PARSOL MCX” (DSM Nutritional Products) is commercially available.
(1)p−メトキシケイ皮酸−2−エチルヘキシルの配合量は、日焼け止め化粧料全量に対して1〜20質量%であることが好ましく、3〜10質量%がさらに好ましい。 (1) The blending amount of p-methoxycinnamic acid-2-ethylhexyl is preferably 1 to 20% by mass, and more preferably 3 to 10% by mass with respect to the total amount of the sunscreen cosmetic.
また、上記特定の(1)ベンゾトリアゾール誘導体と、(3)p−メトキシケイ皮酸2−エチルヘキシルの配合質量比が8:2〜2:8であることが好ましい。 Moreover, it is preferable that the mixing | blending mass ratio of the said specific (1) benzotriazole derivative and (3) 2-ethylhexyl p-methoxycinnamate is 8: 2 to 2: 8.
本発明の日焼け止め化粧料には、上記必須成分以外に、化粧料に通常用いられる成分、例えば、美白剤、保湿剤、酸化防止剤、油性成分、界面活性剤、増粘剤、アルコール類、色剤、水性成分、水、各種皮膚栄養剤等を必要に応じて適宜配合して常法により製造することができる。例えば配合成分としては次のようなものが挙げられる。 In addition to the above essential components, the sunscreen cosmetics of the present invention include components usually used in cosmetics, such as whitening agents, moisturizers, antioxidants, oily components, surfactants, thickeners, alcohols, A coloring agent, an aqueous component, water, various skin nutrients and the like can be appropriately blended as necessary, and can be produced by a conventional method. For example, the following are mentioned as a compounding component.
アボカド油、マカデミアナッツ油、トウモロコシ油、オリーブ油、ナタネ油、月見草油、ヒマシ油、ヒマワリ油、茶実油、コメヌカ油、ホホバ油、カカオ脂、ヤシ油、スクワレン、牛脂、モクロウ、ミツロウ、キャンデリラロウ、カルナバロウ、鯨ロウ、ラノリン、流動パラフィン、ポリオキシエチレン(8モル)オレイルアルコールエーテル、モノオレイン酸グリセリル、シクロメチコン、ジメチルポリシロキサン、ジフェニルポリシロキサンなどの油分。
カプリルアルコール、ラウリルアルコール、ミリスチルアルコール、セチルアルコール、コレステロール、フィトステロールなどの高級アルコール。
カプリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、ラノリン脂肪酸、リノール酸、リノレン酸などの高級脂肪酸。
ポリエチレングリコール、グリセリン、ソルビトール、キシリトール、マルチトール、ムコ多糖、ヒアルロン酸、コンドロイチン硫酸、キトサンなどの保湿剤。
メチルセルロース、エチルセルロース、アラビアガム、ポリビニルアルコールなどの増粘剤。
エタノール、1,3−ブチレングリコールなどの有機溶剤。
ブチルヒドロキシトルエン、トコフェロール、フィチン酸などの酸化防止剤。
安息香酸、サリチル酸、ソルビン酸、パラオキシ安息香酸エステル(エチルパラベン、ブチルパラベンなど)、ヘキサクロロフェンなどの抗菌防腐剤。
グリシン、アラニン、バリン、ロイシン、セリン、トレオニン、フェニルアラニン、チロシン、アスパラギン酸、アスパラギン、グルタミン、タウリン、アルギニン、ヒスチジンなどのアミノ酸と塩酸塩。
アシルサルコシン酸(例えばラウロイルサルコシンナトリウム)、グルタチオン、クエン酸、リンゴ酸、酒石酸、乳酸などの有機酸。
ビタミンA及びその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2及びその誘導体、ビタミンB12、ビタミンB15及びその誘導体などのビタミンB類、アスコルビン酸、アスコルビン酸リン酸エステル(塩)、アスコルビン酸ジパルミテートなどのビタミンC類、α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート、ビタミンEニコチネートなどのビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチンなどのビタミン類。
ニコチン酸アミド、ニコチン酸ベンジル、γ−オリザノール、アラントイン、グリチルリチン酸(塩)、グリチルレチン酸及びその誘導体、ヒノキチオール、ムシジン、ビサボロール、ユーカリプトール、チモール、イノシトール、サポニン類(サイコサポニン、ニンジンサポニン、ヘチマサポニン、ムクロジサポニンなど)、パントテニルエチルエーテル、エチニルエストラジオール、トラネキサム酸、セファランチン、プラセンタエキスなどの各種薬剤。
ギシギシ、クララ、コウホネ、オレンジ、セージ、タイム、ノコギリソウ、ゼニアオイ、センキュウ、センブリ、トウキ、トウヒ、バーチ、スギナ、ヘチマ、マロニエ、ユキノシタ、アルニカ、ユリ、ヨモギ、シャクヤク、アロエ、クチナシ、サワラなどの有機溶剤、アルコール、多価アルコール、水、水性アルコールなどで抽出した天然エキス。
ステアリルトリメチルアンモニウムクロライド、塩化ベンザルコニウム、ラウリルアミンオキサイドなどのカチオン界面活性剤。
エデト酸二ナトリウム、エデト酸三ナトリウム、クエン酸ナトリウム、ポリリン酸ナトリウム、メタリン酸ナトリウム、グルコン酸等の金属封鎖剤。
香料、スクラブ剤、精製水など。
Avocado oil, macadamia nut oil, corn oil, olive oil, rapeseed oil, evening primrose oil, castor oil, sunflower oil, teaseed oil, rice bran oil, jojoba oil, cacao butter, palm oil, squalene, beef tallow, owl, beeswax, candelilla wax Oils such as carnauba wax, whale wax, lanolin, liquid paraffin, polyoxyethylene (8 mol) oleyl alcohol ether, glyceryl monooleate, cyclomethicone, dimethylpolysiloxane, diphenylpolysiloxane.
Higher alcohols such as capryl alcohol, lauryl alcohol, myristyl alcohol, cetyl alcohol, cholesterol, phytosterol.
Higher fatty acids such as capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, lanolin fatty acid, linoleic acid, linolenic acid.
Moisturizers such as polyethylene glycol, glycerin, sorbitol, xylitol, maltitol, mucopolysaccharide, hyaluronic acid, chondroitin sulfate and chitosan.
Thickeners such as methylcellulose, ethylcellulose, gum arabic, and polyvinyl alcohol.
Organic solvents such as ethanol and 1,3-butylene glycol.
Antioxidants such as butylhydroxytoluene, tocopherol and phytic acid.
Antibacterial preservatives such as benzoic acid, salicylic acid, sorbic acid, paraoxybenzoic acid esters (such as ethylparaben and butylparaben), and hexachlorophene.
Amino acids and hydrochlorides such as glycine, alanine, valine, leucine, serine, threonine, phenylalanine, tyrosine, aspartic acid, asparagine, glutamine, taurine, arginine, histidine.
Organic acids such as acyl sarcosine acid (eg, lauroyl sarcosine sodium), glutathione, citric acid, malic acid, tartaric acid, lactic acid.
Vitamin A and its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 and its derivatives, vitamin B such as vitamin B12, vitamin B15 and its derivatives, ascorbic acid, ascorbic acid phosphate ( Salt), vitamin C such as ascorbic acid dipalmitate, α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin E such as vitamin E nicotinate, vitamin D, vitamin H, pantothenic acid, pantethine, etc. Vitamins.
Nicotinamide, benzyl nicotinate, γ-oryzanol, allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and its derivatives, hinokitiol, mucidin, bisabolol, eucalyptol, thymol, inositol, saponins (psychosaponin, carrot saponin, loofima) Various drugs such as saponin, muclodisaponin, etc.), pantothenyl ethyl ether, ethinyl estradiol, tranexamic acid, cephalanthin, placenta extract.
Bark, Clara, Kouhone, Orange, Sage, Thyme, Yarrow, Zeniahoi, Senkyu, Assembly, Spruce, Spruce, Birch, Horsetail, Loofah, Marronie, Yukishinoshita, Arnica, Lily, Mugwort, Peonies, Aloe, Gardenia, Sawara Natural extract extracted with solvent, alcohol, polyhydric alcohol, water, aqueous alcohol.
Cationic surfactants such as stearyltrimethylammonium chloride, benzalkonium chloride, and laurylamine oxide.
Metal sequestering agents such as disodium edetate, trisodium edetate, sodium citrate, sodium polyphosphate, sodium metaphosphate and gluconic acid.
Fragrance, scrub agent, purified water, etc.
本発明の日焼け止め化粧料に配合される好ましい基剤は、デカメチルシクロペンタシロキサン、イソノナン酸イソノニル、ジメチルポリシロキサン、ヘプタメチルオクチルトリシロキサン、トリメチルシロキシケイ酸、流動パラフィン、スクワラン、イソオクタン酸セチル、イソオクタン酸トリグリセライド、コハク酸ジ2−エチルヘキシル等の油分である。これらの油分の一種または二種以上を、上記一般式(I)で示されるベンゾトリアゾール誘導体と共に配合することが好ましい。
本発明は、特にデカメチルシクロペンタシロキサンを主成分基剤とする日焼け止め化粧料に好ましく利用される。
Preferred bases blended in the sunscreen cosmetics of the present invention are decamethylcyclopentasiloxane, isononyl isononanoate, dimethylpolysiloxane, heptamethyloctyltrisiloxane, trimethylsiloxysilicic acid, liquid paraffin, squalane, cetyl isooctanoate, Oils such as isooctanoic acid triglyceride and succinic acid di-2-ethylhexyl. It is preferable to blend one or more of these oils together with the benzotriazole derivative represented by the above general formula (I).
Especially this invention is preferably utilized for the sunscreen cosmetics which have decamethylcyclopentasiloxane as a main component base.
本発明の日焼け止め化粧料は油中水型乳化化粧料(W/Oエマルジョン)であることが好ましく、日焼け止めクリーム、日焼け止めエマルジョン、日焼け止めローション等として好ましく使用できる。 The sunscreen cosmetic of the present invention is preferably a water-in-oil emulsified cosmetic (W / O emulsion), and can be preferably used as a sunscreen cream, sunscreen emulsion, sunscreen lotion and the like.
実施例により本発明を具体的に説明する。本発明はこれらの実施例に限定されない。
配合量は特に断りのない限り質量%である。
The present invention will be specifically described with reference to examples. The present invention is not limited to these examples.
The blending amount is mass% unless otherwise specified.
実施例及び比較例の日焼け止め化粧料(油中水型乳化組成物:サンスクリーン)を常法により製造し、使用感と紫外線吸収効果を評価した。なお、(1)一般式(I)で示されるベンゾトリアゾール誘導体は合成例1の2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールを使用した。 The sunscreen cosmetics of Examples and Comparative Examples (water-in-oil emulsion composition: sunscreen) were produced by conventional methods, and the feeling of use and the ultraviolet absorption effect were evaluated. In addition, (1) 2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole of Synthesis Example 1 was used as the benzotriazole derivative represented by the general formula (I).
「合成例1:2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールの合成」
常法により合成した6−(2H−ベンゾトリアゾール−2−イル)レゾルシノール45.4g(0.20モル)を温度計、還流冷却器を備えた500ml四つ口フラスコに入れ、メチルイソブチルケトン50ml、ジメチルホルムアミド4.0gを加えて撹拌する。この中に炭酸ソーダ25.4g(0.24モル)、および2−エチルヘキシルブロマイド77.2g(0.40モル)を加えて撹拌しながら還流温度まで加熱した。還流温度を保持しながら15時間撹拌した後、メチルイソブチルケトンを常圧で回収して残留したオイルを水洗にて、過剰の炭酸ソーダと生成した無機物を除去する。このオイルから減圧蒸留して220〜225℃/0.2〜0.3mmHgの黄色透明の留分を精製して、2−[4−(2−エチルヘキシルオキシ)−2−ヒドロキシフェニル]−2H−ベンゾトリアゾールを得る。
"Synthesis Example 1: Synthesis of 2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H-benzotriazole"
65.4 g (0.20 mol) of 6- (2H-benzotriazol-2-yl) resorcinol synthesized by a conventional method was placed in a 500 ml four-necked flask equipped with a thermometer and a reflux condenser, and 50 ml of methyl isobutyl ketone, Add 4.0 g of dimethylformamide and stir. To this, 25.4 g (0.24 mol) of sodium carbonate and 77.2 g (0.40 mol) of 2-ethylhexyl bromide were added and heated to the reflux temperature with stirring. After stirring for 15 hours while maintaining the reflux temperature, methyl isobutyl ketone is recovered at normal pressure, and the remaining oil is washed with water to remove excess sodium carbonate and generated inorganic substances. This oil was distilled under reduced pressure to purify a yellow transparent fraction of 220 to 225 ° C./0.2 to 0.3 mmHg to give 2- [4- (2-ethylhexyloxy) -2-hydroxyphenyl] -2H— Benzotriazole is obtained.
「合成例2:2−(2−ヒドロキシ−4−イソブトキシフェニル)−2H−ベンゾトリアゾールの合成」
2−エチルヘキシルブロマイドの替わりに臭化イソブチルを同モル量使用して合成例1と同様に合成を行い、2−(2−ヒドロキシ−4−イソブトキシフェニル)−2H−ベンゾトリアゾールを得る。
"Synthesis Example 2: Synthesis of 2- (2-hydroxy-4-isobutoxyphenyl) -2H-benzotriazole"
Synthesis is carried out in the same manner as in Synthesis Example 1 using the same molar amount of isobutyl bromide instead of 2-ethylhexyl bromide to obtain 2- (2-hydroxy-4-isobutoxyphenyl) -2H-benzotriazole.
<樹脂球状粉末の製造>
〔製造例1〕
ポリアミド12 25重量部、ステアリン酸アルミニウム処理微粒子酸化チタン(平均粒径 15nm、TTO S4 石原産業株式会社)25重量部を超音波分散機を用いて分散した後、オリゴ糖100重量部と200℃に加温混合し、押出機で溶融混練しながらストランド状に押し出した。これを搬送し、450重量部の水の入った容器中に供給して、オリゴ糖を水に溶解させ、酸化チタン内包ポリアミド粒子の水分散液を得た。
次いで、得られた水分散液を連続的に5Cの濾紙で濾過した。回収濾物は再度5重量%となるように水中に分散し、さらに濾過を行った。この操作を3回繰り返すことにより洗浄を行い、乾燥して酸化チタン内包ポリアミド粒子(平均粒径5μm)を得た。
<Production of resin spherical powder>
[Production Example 1]
After 25 parts by weight of polyamide 12 and 25 parts by weight of aluminum stearate-treated fine particle titanium oxide (average particle size 15 nm, TTO S4 Ishihara Sangyo Co., Ltd.) were dispersed using an ultrasonic disperser, 100 parts by weight of oligosaccharide and 200 ° C. The mixture was heated and mixed, and extruded into a strand while melt-kneading with an extruder. This was transported and supplied into a container containing 450 parts by weight of water to dissolve the oligosaccharide in water to obtain an aqueous dispersion of titanium oxide-containing polyamide particles.
Next, the obtained aqueous dispersion was continuously filtered through 5C filter paper. The recovered filtrate was again dispersed in water to 5% by weight and further filtered. This operation was repeated 3 times for washing and drying to obtain titanium oxide-containing polyamide particles (average particle size 5 μm).
〔製造例2〕
樹脂モノマー相
ステアリン酸アルミニウム処理微粒子酸化チタン
(平均粒径 15nm MT−100T テイカ社製) 45重量部
酢酸ビニル(樹脂モノマー) 10重量部
メチルメタクリレート(樹脂モノマー) 34.8重量部
エチレングリコールジメタクリレート(樹脂モノマー) 10重量部
2,2アゾビス2,4ジメチルバレロニトリル(重合開始剤) 0.2重量部
水相
水 500重量部
ポリビニルアルコール(ケン化度87%) 10重量部
樹脂モノマー相を超音波分散機を用いて分散した後、水相に加えてホモミキサーで撹拌してモノマー粒子が4μmになるように調整した。次に、この分散体を攪拌機および温度計を備えた反応装置に移し、55℃に昇温して重合を開始させた。さらに、5時間、この温度で重合させたのち、室温まで冷却し、吸引濾過にて得られた樹脂粉体を分離した。適量の温水そしてメタノールで洗浄したのち、室温にて乾燥させてステアリン酸アルミ処理酸化チタンが45%内包された樹脂球状粉末を得た。
[Production Example 2]
Resin monomer phase Aluminum stearate-treated fine particle titanium oxide (average particle size 15 nm MT-100T manufactured by Teica) 45 parts by weight Vinyl acetate (resin monomer) 10 parts by weight Methyl methacrylate (resin monomer) 34.8 parts by weight Ethylene glycol dimethacrylate ( Resin monomer) 10 parts by weight
2,2
The resin monomer phase was dispersed using an ultrasonic disperser, and then added to the aqueous phase and stirred with a homomixer to adjust the monomer particles to 4 μm. Next, this dispersion was transferred to a reactor equipped with a stirrer and a thermometer, and the temperature was raised to 55 ° C. to initiate polymerization. Furthermore, after making it superpose | polymerize at this temperature for 5 hours, it cooled to room temperature and isolate | separated the resin powder obtained by suction filtration. After washing with an appropriate amount of warm water and methanol, it was dried at room temperature to obtain a spherical resin powder containing 45% aluminum stearate-treated titanium oxide.
*2:酸化チタンTTO-V4(石原産業株式会社製)
*3:超微粒子(平均粒子径15nmの脂肪酸アルミニウムで疎水化処理された酸化チタンを50質量%内包したナイロン粉末(平均粒子径5μm)
* 2: Titanium oxide TTO-V4 (Ishihara Sangyo Co., Ltd.)
* 3: Ultrafine particles (nylon powder containing 50% by mass of titanium oxide hydrophobized with fatty acid aluminum having an average particle size of 15 nm (average particle size 5 μm)
(平均粒子径4μm、内包されている超微粒子酸化チタンの平均粒子径15nm)
*2:酸化チタンTTO-V4(石原産業株式会社製)
* 2: Titanium oxide TTO-V4 (Ishihara Sangyo Co., Ltd.)
<使用感(きしみ感とべたつき)>
専門パネルによる実使用テストを行い、使用感(きしみ感とべたつき)を評価した。その評価基準を以下に示す。本発明の実施例はいずれも優れた使用感を有している。
「きしみ感」
◎:15人以上がきしみ感がないと回答した。
○:10人以上15人未満がきしみ感がないと回答した。
△:5人以上10人未満がきしみ感がないと回答した。
×:5人未満がきしみ感がないと回答した。
「べたつき」
◎:15人以上がべたつかないと回答した。
○:10人以上15人未満がべたつかないと回答した。
△:5人以上10人未満がべたつかないと回答した。
×:5人未満がべたつかないと回答した。
<Usage feeling (squeak and stickiness)>
An actual use test was conducted with a special panel to evaluate the feeling of use (squeak and stickiness). The evaluation criteria are shown below. All the examples of the present invention have an excellent feeling in use.
"Squeaking"
A: 15 or more responded that there was no squeaky feeling.
○: 10 or more and less than 15 responded that there was no squeaky feeling.
Δ: 5 or more and less than 10 responded that there was no squeaky feeling.
X: Less than 5 people answered that there was no squeaky feeling.
"Sticky"
◎: More than 15 people answered that they were not sticky.
○: 10 or more and less than 15 responded that they were not sticky.
Δ: 5 or more and less than 10 people answered that they were not sticky.
×: Less than 5 responded that they were not sticky.
<紫外線吸収効果>
実施例及び比較例のサンプル50μLをナイロン製の膜(5×5cm)に均一に2mg/cm2の割合で塗布し、15分放置後、分光光度計(U−4100:日立製作所)により吸光度を測定した。
結果を図1及び図2に示す。実施例のUV吸収能は比較例よりも遥かに優れていることが分かる。
なお、比較例1のSPF(Sun Protection Factor)は34、PA(Protection Grade of UVA)は+++の機能を有しているので、各実施例のUV吸収能は、SPF30以上PA+++以上となり、高いSPFとPAの機能を有する紫外線防御化粧料といえる。
<Ultraviolet absorption effect>
50 μL of the samples of Examples and Comparative Examples were uniformly applied to a nylon film (5 × 5 cm) at a rate of 2 mg / cm 2 , and allowed to stand for 15 minutes, and then the absorbance was measured with a spectrophotometer (U-4100: Hitachi, Ltd.). It was measured.
The results are shown in FIGS. It can be seen that the UV absorption ability of the examples is far superior to the comparative examples.
In addition, since the SPF (Sun Protection Factor) of Comparative Example 1 has a function of 34 and PA (Protection Grade of UVA) has a function of +++, the UV absorption ability of each Example is SPF 30 or higher and PA ++ or higher, and a high SPF. It can be said that it is a UV protective cosmetic having the function of PA.
次に本発明の日焼け止め化粧料を挙げる。いずれも優れた使用感と紫外線吸収を有し、乳化安定性に優れた日焼け止め化粧料である。 Next, the sunscreen cosmetics of the present invention are listed. All of these are sunscreen cosmetics that have excellent usability and ultraviolet absorption, and are excellent in emulsion stability.
実施例9:日焼け止め乳液(W/O)
質量%
(1)デカメチルシクロペンタシロキサン 20
(2)ポリオキシエチレン・メチルポリシロキサン共重合体 1
(3)オレフィンオリゴマー 10
(4)ジメチルポリシロキサン 5
(5)p−メトキシケイ皮酸−2−エチルヘキシル 7.5
(6)ジメチコジエチルベンザルマロネート 5
(7)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 3
(8)香料 0.5
(9)2,4-ビス-[{4-(2-エチルヘキシルオキシ)-2-ヒドロキシ}-フェニル]-6-(4-メトキシフェニル)-1,3,5-トリアジン 2
(10)ベンゾトリアゾール誘導体(合成例1) 2
(11)樹脂球状粉末*1 10
(12)1.3ブチレングリコール 5
(13)イオン交換水 残余
(14)グリセリン 3
(15)エデト酸塩 適量
*1:製造例2で得られた内部にステアリン酸アルミニウムで疎水化処理された超微粒子酸化チタンを45質量%含有したポリアクリル酸球状粉末
(平均粒子径4μm、内包されている超微粒子酸化チタンの平均粒子径15nm)
製造方法:
(1)〜(9)を室温で混合溶解し、予め油相を調整しておく。次に、(10)を加え、ディスパーで分散混合する。(11)〜(15)を混合溶解してから油相へディスパーで攪拌しながら徐々に添加し、十分均一に混合溶解して目的の日焼け止め乳液を得る。
Example 9: Sunscreen emulsion (W / O)
mass%
(1) Decamethylcyclopentasiloxane 20
(2) Polyoxyethylene /
(3) Olefin oligomer 10
(4) Dimethylpolysiloxane 5
(5) p-methoxycinnamic acid-2-ethylhexyl 7.5
(6) Dimethicodiethylbenzalmalonate 5
(7) Diethylaminohydroxybenzoyl hexyl benzoate 3
(8) Fragrance 0.5
(9) 2,4-bis-[{4- (2-ethylhexyloxy) -2-hydroxy} -phenyl] -6- (4-methoxyphenyl) -1,3,5-
(10) Benzotriazole derivative (Synthesis example 1) 2
(11) Resin spherical powder * 1 10
(12) 1.3 Butylene glycol 5
(13) Ion exchange water Residual (14) Glycerin 3
(15) Edetate Appropriate amount * 1: Polyacrylic acid spherical powder containing 45% by mass of ultrafine titanium oxide hydrophobized with aluminum stearate inside obtained in Production Example 2 (average particle size 4 μm, inclusion The average particle diameter of the ultrafine titanium oxide that is used is 15 nm)
Production method:
(1) to (9) are mixed and dissolved at room temperature, and the oil phase is adjusted in advance. Next, (10) is added and dispersed and mixed with a disper. (11) to (15) are mixed and dissolved, and then gradually added to the oil phase while stirring with a disper, and mixed and dissolved sufficiently uniformly to obtain the desired sunscreen emulsion.
実施例10:日焼け止め乳液(W/O)
質量%
(1)デカメチルシクロペンタシロキサン 15
(2)ポリオキシエチレン・メチルポリシロキサン共重合体 1
(3)オレフィンオリゴマー 10
(4)ジメチルポリシロキサン 10
(5)p−メトキシケイ皮酸−2−エチルヘキシル 7.5
(6)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 5
(7)メチレンビスベンゾトリアゾールテトラメチルブチルフェノールの水分散物*1
2
(8)香料 0.5
(9)ジメチコジエチルベンザルマロネート 5
(10)ベンゾトリアゾール誘導体(合成例2) 2
(11)樹脂球状粉末*2 5
(12)疎水化処理微粒子酸化亜鉛 10
(13)パラベン 5
(14)イオン交換水 残余
(15)グリセリン 3
(16)エデト酸塩 適量
*1 チバ社から「チノソーブM」の名称で市販されている
*2 Z−COTE HP1 (BASF社)
製造方法:
(1)〜(10)を室温で混合溶解し、予め油相を調整しておく。次に、(11)〜(12)を加え、ディスパーで分散混合する。(11)〜(16)を混合溶解してから油相へディスパーで攪拌しながら徐々に添加し、十分均一に混合溶解して目的の日焼け止め乳液を得る。
Example 10: Sunscreen emulsion (W / O)
mass%
(1) Decamethylcyclopentasiloxane 15
(2) Polyoxyethylene /
(3) Olefin oligomer 10
(4) Dimethylpolysiloxane 10
(5) p-methoxycinnamic acid-2-ethylhexyl 7.5
(6) Diethylaminohydroxybenzoyl hexyl benzoate 5
(7) Methylenebisbenzotriazole tetramethylbutylphenol aqueous dispersion * 1
2
(8) Fragrance 0.5
(9) Dimethicodiethylbenzalmalonate 5
(10) Benzotriazole derivative (Synthesis example 2) 2
(11) Resin spherical powder * 2 5
(12) Hydrophobized fine particle zinc oxide 10
(13) Paraben 5
(14) Ion exchange water Residual (15) Glycerin 3
(16) Edetate salt * 1 Z-COTE HP1 (BASF) commercially available from Ciba under the name “Chinosorb M”
Production method:
(1) to (10) are mixed and dissolved at room temperature, and the oil phase is adjusted in advance. Next, (11) to (12) are added and dispersed and mixed with a disper. (11) to (16) are mixed and dissolved and then gradually added to the oil phase while stirring with a disper, and mixed and dissolved sufficiently uniformly to obtain the desired sunscreen emulsion.
実施例11:日焼け止めクリーム(O/W)
質量%
(1)カルボキシビニルポリマー 0.3
(2)精製水 残余
(3)キサンタンガム 0.1
(4)エデト酸3ナトリウム 0.1
(5)グリチルリチン酸ジカリウム 0.05
(6)1,3−ブチレングリコール 5
(7)イソステアリン酸ポリオキシエチレングリセリル 1.5
(8)モノステアリン酸ポリオキシエチレングリセリン 1
(9)L−アスコルビン酸2−グルコシド 2
(10)フェノキシエタノール 適量
(11)デカメチルシクロペンタシロキサン 3
(12)メチルフェニルポリシロキサン 3
(13)ベヘニルアルコール 1
(14)p−メトキシケイ皮酸−2−エチルヘキシル 7
(15)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 2
(16)2,4-ビス-[{4-(2-エチルヘキシルオキシ)-2-ヒドロキシ}-フェニル]-6-(4-メトキシフェニル)-1,3,5-トリアジン 2
(17)ベンゾトリアゾール誘導体(合成例1) 3
(18)香料 適量
(19)樹脂球状粉末*1 5
*1:製造例2で得られた内部にステアリン酸アルミニウムで疎水化処理された超微粒子酸化チタンを45質量%含有したポリアクリル酸球状粉末
(平均粒子径4μm、内包されている超微粒子酸化チタンの平均粒子径15nm)
製造方法:
(1)〜(10)を70℃に加熱混合溶解し、水相を調整しておく。次に、(11)〜(18)を加熱混合溶解して油相を調整し、(19)をディスパー分散を行ない、水相へディスパーで攪拌しながら徐々に添加し、十分均一に混合溶解して目的の日焼け止めクリームを得る。
Example 11: Sunscreen cream (O / W)
mass%
(1) Carboxyvinyl polymer 0.3
(2) Purified water Residual (3) Xanthan gum 0.1
(4) edetate trisodium 0.1
(5) Dipotassium glycyrrhizinate 0.05
(6) 1,3-butylene glycol 5
(7) Polyoxyethylene glyceryl isostearate 1.5
(8) Polystearic
(9) L-ascorbic acid 2-
(10) Appropriate amount of phenoxyethanol (11) Decamethylcyclopentasiloxane 3
(12) Methylphenylpolysiloxane 3
(13)
(14) p-methoxycinnamic acid-2-ethylhexyl 7
(15)
(16) 2,4-bis-[{4- (2-ethylhexyloxy) -2-hydroxy} -phenyl] -6- (4-methoxyphenyl) -1,3,5-
(17) Benzotriazole derivative (Synthesis example 1) 3
(18) Perfume appropriate amount (19) Resin spherical powder * 15
* 1: Polyacrylic acid spherical powder containing 45% by mass of ultrafine particle titanium oxide hydrophobized with aluminum stearate obtained in Production Example 2 (average particle size 4 μm, encapsulated ultrafine particle titanium oxide Average particle diameter of 15 nm)
Production method:
(1) to (10) are heated and mixed and dissolved at 70 ° C. to adjust the aqueous phase. Next, (11) to (18) are heated and mixed and dissolved to adjust the oil phase, and (19) is dispersed with disper and gradually added to the aqueous phase while stirring with a disper, and mixed and dissolved sufficiently uniformly. To get the desired sunscreen cream.
実施例12:日焼け止めクリーム(W/O)
質量%
(1)デカメチルシクロペンタシロキサン 20
(2)ポリオキシエチレン・メチルポリシロキサン共重合体 3
(3)セチルイソオクタノエート 10
(4)ジメチルポリシロキサン 5
(5)p−メトキシケイ皮酸−2−エチルヘキシル 5
(6)ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 1
(7)2,4-ビス-[{4-(2-エチルヘキシルオキシ)-2-ヒドロキシ}-フェニル]-6-(4-メトキシフェニル)-1,3,5-トリアジン 3
(8)ベンゾトリアゾール誘導体(合成例1) 3
(9)オクトクリレン 3
(10)塩化ジステアリルジアンモニウム 0.001
(11)フェノキシエタノール 0.5
(12)香料 0.5
(13)有機変性粘土鉱物 2.5
(14)樹脂球状粉末*2 5
(15)フェニルベンズイミダゾールスルホン酸 3
(16)トリエタノールアミン 1.8
(17)イオン交換水 残余
(18)1.3ブチレングリコール 2
(19)エデト酸塩 適量
*2 Z−COTE HP1 (BASF社)
製造方法:
(1)〜(12)を70℃に加熱混合溶解し、予め油相を調整しておく。次に、(13)〜(14)を加え、ディスパーで分散混合する。(15)〜(19)を混合溶解してから油相へディスパーで攪拌しながら徐々に添加し、十分均一に混合溶解して目的の日焼け止めクリームを得る。
Example 12: Sunscreen cream (W / O)
mass%
(1) Decamethylcyclopentasiloxane 20
(2) Polyoxyethylene / methylpolysiloxane copolymer 3
(3) Cetyl isooctanoate 10
(4) Dimethylpolysiloxane 5
(5) p-methoxycinnamic acid-2-ethylhexyl 5
(6)
(7) 2,4-bis-[{4- (2-ethylhexyloxy) -2-hydroxy} -phenyl] -6- (4-methoxyphenyl) -1,3,5-triazine 3
(8) Benzotriazole derivative (Synthesis example 1) 3
(9) Octocrylene 3
(10) Distearyl diammonium chloride 0.001
(11) Phenoxyethanol 0.5
(12) Fragrance 0.5
(13) Organically modified clay mineral 2.5
(14) Resin spherical powder * 2 5
(15) Phenylbenzimidazolesulfonic acid 3
(16) Triethanolamine 1.8
(17) Ion exchange water Residual (18) 1.3
(19) Edetic acid salt appropriate amount * 2 Z-COTE HP1 (BASF)
Production method:
(1) to (12) are heated and mixed and dissolved at 70 ° C., and the oil phase is adjusted in advance. Next, (13) to (14) are added and dispersed and mixed with a disper. (15) to (19) are mixed and dissolved, and then gradually added to the oil phase while stirring with a disper, and mixed and dissolved sufficiently uniformly to obtain the intended sunscreen cream.
本発明によれば、優れた紫外線防御効果を有し、極めて優れた使用感を有する日焼け止め化粧料を提供できる。本発明は油中水型乳化日焼け止め化粧料として特に有用である。 ADVANTAGE OF THE INVENTION According to this invention, it has the outstanding ultraviolet protection effect and can provide the sunscreen cosmetics which have the very outstanding feeling of use. The present invention is particularly useful as a water-in-oil type emulsion sunscreen cosmetic.
Claims (6)
一般式(I)
(2)内部に疎水化処理された超微粒子酸化チタンを35質量%以上含有した樹脂球状粉末と
を配合することを特徴とする日焼け止め化粧料。 (1) a benzotriazole derivative represented by the following general formula (I);
Formula (I)
(2) A sunscreen cosmetic comprising a resin spherical powder containing 35% by mass or more of ultrafine titanium oxide hydrophobized inside.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009218817A JP2011068566A (en) | 2009-09-24 | 2009-09-24 | Sunscreen cosmetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009218817A JP2011068566A (en) | 2009-09-24 | 2009-09-24 | Sunscreen cosmetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2011068566A true JP2011068566A (en) | 2011-04-07 |
Family
ID=44014218
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009218817A Withdrawn JP2011068566A (en) | 2009-09-24 | 2009-09-24 | Sunscreen cosmetic |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2011068566A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015063485A (en) * | 2013-09-25 | 2015-04-09 | ロート製薬株式会社 | External composition |
-
2009
- 2009-09-24 JP JP2009218817A patent/JP2011068566A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015063485A (en) * | 2013-09-25 | 2015-04-09 | ロート製薬株式会社 | External composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5553377B2 (en) | Sunscreen cosmetics | |
| EP2027847A1 (en) | Sunscreen preparations | |
| JPWO2010110020A1 (en) | Sunscreen cosmetics | |
| JPH07252123A (en) | Antisun cosmetic composition, method for producing the same and use thereof | |
| JP5083933B2 (en) | Sunscreen cosmetics | |
| JP2009102236A (en) | Oil-in-water type emulsified composition and its manufacturing method | |
| KR20200011434A (en) | Cosmetics | |
| CN101460135A (en) | Sunscreen preparations | |
| JP5540243B2 (en) | Sunscreen cosmetics | |
| WO2010026755A1 (en) | Sunscreen cosmetic | |
| JP3843627B2 (en) | Sunscreen cosmetics | |
| CN102781403B (en) | Fast light barrier compositions | |
| JP4827877B2 (en) | Sunscreen cosmetics | |
| JP2007182388A (en) | Sunscreen cosmetic | |
| JP2011068566A (en) | Sunscreen cosmetic | |
| JP2007099699A (en) | Sunscreen cosmetic | |
| JP2018131411A (en) | Sunscreen cosmetics | |
| JP2007182387A (en) | Sunscreen cosmetic | |
| JP2007182389A (en) | Sunscreen oil-in-water type emulsion cosmetic | |
| CN100343377C (en) | O/W emulsifier, O/W emulsion and its use | |
| JP2004051550A (en) | Foundation composition | |
| JP2007126426A (en) | Sun-screening cosmetic | |
| JP2007106701A (en) | Sunscreen cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20121204 |